Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CATALYST PHARM PARTNERS INC Analyst Recommendations

  • Analyst Consensus: CPRX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.333 Hold 3
    30 Days Ago 3.667 Underperform 3
    60 Days Ago 3.000 Hold 3
    90 Days Ago 3.000 Hold 3
    120 Days Ago 3.000 Hold 3

  • Analyst Ratings: CPRX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Merriman Sell Neutral 10/01/2009 —
    Merriman Curhan Ford Buy Sell 05/29/2009 —
    Hapoalim Neutral Underperform 05/29/2009 —
    Merriman Curhan Ford — Buy 12/14/2008 —
    Rodman & Renshaw — Mkt Outperform 11/28/2007 9.00
    Stifel Nicolaus — Buy 01/31/2007 9.00
    First Albany — Buy 01/05/2007 10.00